Company Overview and News


Add SUD
to your dashboard

Headline News

SUDA in deal to develop oro-mucosal spray of anti-cancer agent

2017-06-20 proactiveinvestors.com.au
SUDA (ASX:SUD) has signed an agreement with UK-based Aluztra Bio to acquire the global intellectual property relating to a novel anti-cancer agent, Anagrelide.

SUDA to lift cash balance

2017-04-05 proactiveinvestors.com.au
Suda (ASX:SUD) has been granted a trading halt by the ASX this morning, with its shares placed in pre-open.

SUDA moves a step closer to commercialise its spray to fight malaria

2017-04-03 proactiveinvestors.com.au
SUDA (ASX:SUD) has submitted the marketing authorisation application (MAA) for its ArTiMist® spray to the Australian Therapeutic Goods Administration (TGA).

Investor presentation

2016-05-03 asx.com.au

Appendix 4C - quarterly

2016-04-29 asx.com.au

Business development update

2016-04-19 asx.com.au

Appendix 3B

2016-03-08 asx.com.au

SUDA Ltd investor presentation

2016-02-25 asx.com.au

SUDA LTD Shareholder Update

2016-02-08 asx.com.au